Subscribe Us

header ads

Recents

header ads

Cancer Diagnostics Market Size, Growth, Demands Outlook and Forecasts to 2030

Precedence Research - December 29, 2022

According to the research report, the global cancerdiagnostics market size is expected to touch USD 258.54 Billion by 2030, from USD 124.96 Billion in 2021, growing with a significant CAGR of 8.4% from 2022 to 2030. 

Cancer Diagnostics Market Size 2022-2030

The cancer diagnostics market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global cancer diagnostics market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global cancer diagnostics market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global cancer diagnostics market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1194

 Scope of the Report

Report HighlightsDetails
Market SizeUS$ 258.54 Billion by 2030
Growth RateCAGR of 8.4% From 2022 to 2030
Base Year2021
Historic Data2017 to 2021
Forecast Period2022 to 2030
Segments CoveredTest Type, Application
Regional ScopeNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

This study covers a detailed segmentation of the global cancer diagnostics market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global cancer diagnostics market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

 

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Becton, Dickinson and Company
  • GE Healthcare
  • QIAGEN N.V.
  • Abbott Laboratories, Inc.
  • Roche Diagnostics
  • Siemens Healthcare
  • Philips Healthcare
  • R. Bard, Inc.
  • bioMérieux SA
  • NeoGenomics Laboratories, Inc.
  • Volpara Solutions Limited
  • Hologic Inc.
  • Canon Medical Systems Corporation
  • PenRad Technologies Inc.
  • BioNTech Diagnostics GmbH
  • BioGenex

Market Segmentation

 By Product

  • Consumables
    • Antibodies
    • Kits & Reagents
    • Probes
    • Other Consumables
  • Instruments
    • Pathology-based Instruments
    • Slide Staining Systems
    • Tissue Processing Systems
    • Cell Processors
    • PCR Instruments
    • NGS Instruments
    • Microarrays
    • Other Pathology-based Instruments
  • Imaging Instruments
    • CT Systems
    • Ultrasound Systems
    • MRI Systems
    • Mammography Systems
    • Nuclear Imaging Systems
  • Biopsy Instruments

By Technology

  • IVD Testing
    • Polymerase Chain Reaction (PCR)
    • In Situ Hybridization (ISH)
    • Immunohistochemistry (IHC)
    • Next-generation Sequencing (NGS)
    • Microarrays
    • Flow Cytometry
    • Immunoassays
    • Other IVD Testing Technologies
  • Imaging
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • Positron Emission Tomography (PET)
    • Mammography
    • Ultrasound
  • Biopsy Technique

By Application

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Lung Cancer
  • Prostate Cancer
  • Skin Cancer
  • Blood Cancer
  • Kidney Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Others

By End Use

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Diagnostic Imaging Centers
  • Research Institutes

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global cancer diagnostics market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global cancer diagnostics market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cancer Diagnostics Market 

5.1. COVID-19 Landscape: Cancer Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cancer Diagnostics Market, By Product

8.1. Cancer Diagnostics Market, by Product Type, 2022-2030

8.1.1. Consumables (Antibodies, Kits & Reagents, Probes, Other Consumables)

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Instruments (Pathology-based Instruments, Slide Staining Systems, Tissue Processing Systems, Cell Processors, Others)

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Imaging Instruments (CT Systems, Ultrasound Systems, MRI Systems, Mammography Systems, Nuclear Imaging Systems)

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Biopsy Instruments

8.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Cancer Diagnostics Market, By Technology

9.1. Cancer Diagnostics Market, by Technology, 2022-2030

9.1.1. IVD Testing (PCR, ISH, IHC, NGS, Microarrays, Flow Cytometry, Immunoassays)

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Imaging (MRI, CT, PET, Mammography, Ultrasound)

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Biopsy Technique

9.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Cancer Diagnostics Market, By Application 

10.1. Cancer Diagnostics Market, by Application, 2022-2030

10.1.1. Breast Cancer

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Colorectal Cancer

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Cervical Cancer

10.1.3.1. Market Revenue and Forecast (2019-2030)

10.1.4. Lung Cancer

10.1.4.1. Market Revenue and Forecast (2019-2030)

10.1.5. Prostate Cancer

10.1.5.1. Market Revenue and Forecast (2019-2030)

10.1.6. Skin Cancer

10.1.6.1. Market Revenue and Forecast (2019-2030)

10.1.7. Blood Cancer

10.1.7.1. Market Revenue and Forecast (2019-2030)

10.1.8. Kidney Cancer

10.1.8.1. Market Revenue and Forecast (2019-2030)

10.1.9. Liver Cancer

10.1.9.1. Market Revenue and Forecast (2019-2030)

10.1.10. Pancreatic Cancer

10.1.10.1. Market Revenue and Forecast (2019-2030)

10.1.11. Ovarian Cancer

10.1.11.1. Market Revenue and Forecast (2019-2030)

10.1.12. Others

10.1.12.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Cancer Diagnostics Market, By End Use 

11.1. Cancer Diagnostics Market, by End Use, 2022-2030

11.1.1. Hospitals and Clinics

11.1.1.1. Market Revenue and Forecast (2019-2030)

11.1.2. Diagnostic Laboratories

11.1.2.1. Market Revenue and Forecast (2019-2030)

11.1.3. Diagnostic Imaging Centers

11.1.3.1. Market Revenue and Forecast (2019-2030)

11.1.4. Research Institutes

11.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 12. Global Cancer Diagnostics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.2. Market Revenue and Forecast, by Technology (2019-2030)

12.1.3. Market Revenue and Forecast, by Application (2019-2030)

12.1.4. Market Revenue and Forecast, by End Use (2019-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.5.2. Market Revenue and Forecast, by Technology (2019-2030)

12.1.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.1.5.4. Market Revenue and Forecast, by End Use (2019-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.6.2. Market Revenue and Forecast, by Technology (2019-2030)

12.1.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.1.6.4. Market Revenue and Forecast, by End Use (2019-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.2. Market Revenue and Forecast, by Technology (2019-2030)

12.2.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.4. Market Revenue and Forecast, by End Use (2019-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.5.2. Market Revenue and Forecast, by Technology (2019-2030)

12.2.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.5.4. Market Revenue and Forecast, by End Use (2019-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.6.2. Market Revenue and Forecast, by Technology (2019-2030)

12.2.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.6.4. Market Revenue and Forecast, by End Use (2019-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.7.2. Market Revenue and Forecast, by Technology (2019-2030)

12.2.7.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.7.4. Market Revenue and Forecast, by End Use (2019-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.8.2. Market Revenue and Forecast, by Technology (2019-2030)

12.2.8.3. Market Revenue and Forecast, by Application (2019-2030)

12.2.8.4. Market Revenue and Forecast, by End Use (2019-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.2. Market Revenue and Forecast, by Technology (2019-2030)

12.3.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.4. Market Revenue and Forecast, by End Use (2019-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.5.2. Market Revenue and Forecast, by Technology (2019-2030)

12.3.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.5.4. Market Revenue and Forecast, by End Use (2019-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.6.2. Market Revenue and Forecast, by Technology (2019-2030)

12.3.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.6.4. Market Revenue and Forecast, by End Use (2019-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.7.2. Market Revenue and Forecast, by Technology (2019-2030)

12.3.7.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.7.4. Market Revenue and Forecast, by End Use (2019-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.8.2. Market Revenue and Forecast, by Technology (2019-2030)

12.3.8.3. Market Revenue and Forecast, by Application (2019-2030)

12.3.8.4. Market Revenue and Forecast, by End Use (2019-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.2. Market Revenue and Forecast, by Technology (2019-2030)

12.4.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.4. Market Revenue and Forecast, by End Use (2019-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.5.2. Market Revenue and Forecast, by Technology (2019-2030)

12.4.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.5.4. Market Revenue and Forecast, by End Use (2019-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.6.2. Market Revenue and Forecast, by Technology (2019-2030)

12.4.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.6.4. Market Revenue and Forecast, by End Use (2019-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.7.2. Market Revenue and Forecast, by Technology (2019-2030)

12.4.7.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.7.4. Market Revenue and Forecast, by End Use (2019-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.8.2. Market Revenue and Forecast, by Technology (2019-2030)

12.4.8.3. Market Revenue and Forecast, by Application (2019-2030)

12.4.8.4. Market Revenue and Forecast, by End Use (2019-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.2. Market Revenue and Forecast, by Technology (2019-2030)

12.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.5.4. Market Revenue and Forecast, by End Use (2019-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.5.2. Market Revenue and Forecast, by Technology (2019-2030)

12.5.5.3. Market Revenue and Forecast, by Application (2019-2030)

12.5.5.4. Market Revenue and Forecast, by End Use (2019-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.6.2. Market Revenue and Forecast, by Technology (2019-2030)

12.5.6.3. Market Revenue and Forecast, by Application (2019-2030)

12.5.6.4. Market Revenue and Forecast, by End Use (2019-2030)

Chapter 13. Company Profiles

13.1. Agilent Technologies, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Thermo Fisher Scientific, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Illumina, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Becton, Dickinson and Company

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. GE Healthcare

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. QIAGEN N.V.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Abbott Laboratories, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Roche Diagnostics

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Siemens Healthcare

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Philips Healthcare

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

13.11. R. Bard, Inc. 

13.11.1. Company Overview

13.11.2. Product Offerings

13.11.3. Financial Performance

13.11.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Tags:

Post a Comment

0 Comments